Complement Therapeutics Company
Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.
Headquarters:
London, England, United Kingdom
Employee Number:
11-50
Estimated Revenue:
£780 000-7 800 000
Founded Date:
2020
Industry:
Geroscience